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1 
45 Summary 
46 Transposon mutagenesis has been applied to a hyper-invasive clinical isolate of C. 
47 jejuni, 01/51. A random transposon mutant library was screened in an in vitro assay of 
48 invasion and 26 mutants with a significant reduction in invasion were identified. 
49 Given that the invasion potential of C. jejuni is relatively poor compared to other 
50 enteric pathogens the use of a hyper-invasive strain was advantageous as it greatly 
51 facilitated the identification of mutants with reduced invasion. The location of the 
52 transposon insertion in 23 of these mutants has been determined, all but three of 
53 which are in genes also present in the genome sequenced strain N C T C l 1168. Eight of 
54 the mutants contain transposon insertions in one region of the genome (ca. 14kb) 
55 which when compared with the genome of N C T C l 1168 overlaps with one of the 
56 previously reported plasticity regions and is likely to be involved in genomic variation 
57 between strains. Further characterisation of one of the mutants within this region has 
58 identified a gene that might be involved in adhesion to host cells. 
59 
2 
60 Introduction 
61 Campylobacter jejuni is the main cause of human acute bacterial enteritis in the 
62 developed world. In England and Wales in 2008 there were 49,880 reported cases of 
63 C jejuni gastroenteritis (Health Protection Agency Centre for Infections), which is 
64 thought to be a significant underestimate (Tompkins et al., 1999). The disease itself is 
65 usually self-limiting and the main symptoms in developed countries, such as the U K 
66 and US, are abdominal pain and diarrhoea, often with mucous and blood in the stool 
67 (Ketley, 1997; Tompkins et al, 1999; Wassenaar & Blaser, 1999). Nevertheless this 
68 organism is still the most common cause of food-borne intestinal infectious disease 
69 and is a significant public health burden. 
70 
71 C. jejuni is an invasive organism and there is much evidence, from both in vivo and in 
72 vitro studies, that invasion is a virulence mechanism used by Campylobacters (De 
73 Melo et al, 1989; Fauchere et al, 1986; Garrity et al, 2005; Klipstein et al, 1985; 
74 Konkel & Joens, 1989). In the absence of a suitable animal model that mimics human 
75 disease (Newell, 2001) invasion has been studied using in vitro cell culture. There 
76 have been many reports of in vitro cell culture models of invasion for Campylobacter 
77 and these have recently been reviewed (Friis et al, 2005). As in other 
78 enteropathogens, variation in virulence also exists between strains of C jejuni. This 
79 has been observed for invasion and adhesion as well as toxicity (Abuoun et al, 2005; 
80 Everest et al, 1992; Gilbert & Slavik, 2004; Konkel & Joens, 1989; Newell et al, 
81 1985; Wassenaar, 1997). A number of hyper-invasive clinical strains of C jejuni have 
82 recently been identified (Fearnley et al, 2008). These isolates were found to invade 
83 the human epithelial cell lines INT-407 and Caco-2 to significantly higher levels (>25 
84 fold) compared with a low-invasive control strain of C jejuni 81116 (NCTC11828). 
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85 These strains therefore provide a unique opportunity to investigate the molecular basis 
86 of invasion as any reduction in invasion would be much easier to identify compared to 
87 using low invasive strains like 81116. It should however be noted that these hyper-
88 invasive strains may use different invasion strategies to other non-hyper-invasive 
89 strains and so the role of any genes in invasion should be confirmed using strains with 
90 varying levels of invasion. 
91 
92 Molecular techniques to investigate virulence mechanisms are now available for use 
93 in C. jejuni. Over the last few years the development of transposon mutagenesis for C. 
94 jejuni has advanced significantly and several methods are now available for the 
95 random mutagenesis of this organism (Colegio et al, 2001; Golden et al, 2000; 
96 Golden & Acheson, 2002; Hendrixson et al, 2001; Hendrixson & DiRita, 2004). One 
97 method in particular utilises an in vitro method of transposition, using a mariner-
98 based transposon, followed by natural transformation to introduce the mutated 
99 genomic D N A back into the host strain (Grant et al, 2005). This is a particularly 
100 useful technique as many strains of C. jejuni will not take up heterologous DNA. 
101 Previously transposon mutagenesis has been limited to a handful of those strains for 
102 which genetic manipulation is relatively easy and many of these strains have a 
103 relatively low invasion potential. However using this in vitro system a transposon 
104 mutant library has been constructed in a hyper-invasive clinical isolate of C. jejuni, 
105 strain 01/51 (Fearnley et al, 2008), providing a unique opportunity to investigate the 
106 molecular basis of invasion in a strain with a significantly high level of invasion. 
107 
108 The aim of this study was to investigate the molecular basis of host cell invasion in C. 
109 jejuni by applying transposon mutagenesis to a hyper-invasive strain. We report the 
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110 screening of this mutant library in an in vitro assay of invasion and the identification 
111 of a number of previously uncharacterised genes that have a role in invasion. Mutants 
112 were selected for confirmatory assays and further study on the basis of their reduced 
113 level of invasion and maintenance of motility compared to the wild-type strain 01/51. 
114 We also identify a region of the C. jejuni genome known to be variable between 
115 strains (Pearson et al, 2003) in which several genes with a role in invasion are 
116 located. 
117 
118 Materials and Methods 
119 Bacterial strains and growth media. Six clinical Campylobacter jejuni isolates were 
120 used in this study: 01/38, 01/41, 01/51, 01/35, 01/10, 01/04, all of which were human 
121 faecal isolates apart from 01/10 and 01/04, which were isolated as a blood culture 
122 from patients with bacteraemia. These clinical strains were selected on the basis that 
123 they were all hyper-invasive (>25 fold as invasive as the control strain 81116) in an in 
124 vitro assay of invasiveness, apart from 01/38 which was found to be highly invasive 
125 (>10 fold as invasive as the control strain 81116) (Fearnley et al, 2008). Strain 01/38 
126 was included just in case it proved difficult to generate a random mutant library in one 
127 of the hyper-invasive strains. The non-motile, non-invasive mutant C. jejuni 81116 
128 flahJflaB' (Wassenaar et al, 1991) was used as a negative control in the invasion 
129 assays. NCTC11168 and RM1221 were both used as reference strains for 
130 investigation of the TTT trinucleotide sequence (see later). Al l C. jejuni strains were 
131 routinely grown on blood agar (BA) plates (Columbia agar supplemented with 5% 
132 (v/v) sheep blood) or mCCDA agar (Oxoid) at 37°C in a microaerobic atmosphere 
133 (10% (v/v) C02 , 5% (v/v) 02, 85% (v/v) N2) for 24-48 hours. When required the 
134 medium was also supplemented with 10 ug chloramphenicol per ml, or 50 ug 
5 
135 kanamycin per ml. The transposon mutants (n=864) were grown in each well of a 96-
136 well plate containing 100 ul B A supplemented with 10 ug chloramphenicol per ml. 
137 E. coli strains were grown in Luria-Bertani (LB) broth with shaking, or on LB agar 
138 plates, aerobically at 37°C. The following antibiotics were added when required: 100 
139 ug ampicillin per ml, 50 ug kanamycin per ml. 
140 
141 Generation of a random transposon mutant library. The random transposon mutant 
142 library was generated and the randomness assessed as previously described (Grant et 
143 al, 2005). 
144 
145 In vitro adhesion and invasion assay. The semi-quantitative invasion assay used was 
146 an adaptation of the gentamicin protection assay, using the human intestinal epithelial 
147 cell line, INT-407 (Elsinghorst, 1994; Fearnley et al, 2008). Note that it is now 
148 generally recognised that the INT-407 cell line was contaminated with HeLa cells in 
149 the 1970s and therefore has cellular markers consistent with this contamination 
150 (Lacroix, 2008), however it is still widely used for studying invasion and in our study 
151 it was used as a preliminary screen with confirmation of any mutants of interest using 
152 the alternative cell line Caco-2. For preliminary screening of the transposon mutants a 
153 96-well plate assay was adapted from that described by Golden and Acheson (Golden 
154 & Acheson, 2002). Briefly, the frozen transposon mutant library was thawed on ice 
155 and 10 ul of each mutant transferred to B A (100 ul) supplemented with 
156 chloramphenicol (10 ug/ml) in each well of a 96-well plate. The plates were incubated 
157 at 37°C microaerobically for 48 hours. Meanwhile 200 ul of INT-407 cells at a 
158 density of 1 x 105 cells per ml was seeded to each well of a fresh 96-well plate and 
159 incubated for 48 hours at 37°C in 5 % (v/v) CO2 to allow the cells to grow to 
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160 confluency. On the day of the assay, the cell culture media covering the INT-407 cell 
161 monolayers was replaced with 200 ul fresh pre-warmed complete cell culture media 
162 (CCCM). Fresh C C C M (100 ul) was also added to each well of the plate containing 
163 bacterial growth and left for 5-10 min for the colonies to soften. The bacterial cells 
164 were resuspended by pipetting and 20 ul of the suspension was added to the 200 ul of 
165 media in each well covering the INT-407 monolayers. Given the number of mutants 
166 tested in this way it was very difficult to normalise the starting bacterial cell 
167 concentration, however any mutants that did not grow well prior to the assay were 
168 noted and removed from further study. Infected plates were incubated for 3 hours at 
169 37°C in 5% (v/v) CO2. After incubation, monolayers were washed and then 200 ul 
170 C C C M supplemented with 250 ug gentamicin per ml was added. Following 2 hours 
171 of incubation, monolayers were washed and the cells lysed with 100 ul 1 % (v/v) 
172 Triton-XlOO. The total number of bacteria per well was determined by viable count 
173 and plating onto B A plates. C. jejuni 01/51 and C. jejuni 81116 JlaA'/flaB' . 
174 (Wassenaar et al, 1991) were also used as reference parent strain and negative 
175 control, respectively, in the assays. The preliminary invasion screening assay was 
176 repeated three times independently. Mutants that consistently showed a reduced 
177 recovery compared to the parent strain 01/51 following the assay were selected for 
178 further characterisation including motility and confirmation of the reduced invasion 
179 phenotype using a standardised assay as described below. 
180 For a more quantitative analysis and confirmation of the invasion of selected mutants 
181 standard gentamicin protection assays (confirmatory assay) using both INT-407 and 
182 Caco-2 cells in 24-well plates were carried out, in which each mutant was assayed in 
183 triplicate. The mutants were grown on B A plates for 48 hours and were added to the 
184 monolayers at a multiplicity of infection (MOI) of 100. To determine the number of 
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185 associated bacteria, the INT-407 cells were lysed after the initial 3 hour incubation 
186 period and the bacterial cells enumerated by plate count. This gives the total number 
187 of bacteria that are associated and internalised. The number of associated bacteria was 
188 then calculated by subtracting the number of internalised bacteria from the total 
189 number counted. Invasion efficiency was expressed as the percent of the inoculum 
190 that survived the gentamicin treatment. 
191 
192 Motility assay. Bacterial motility was tested as described previously (Fearnley et al, 
193 2008). The parent strain 01/51 was assumed to have 100% motility (with an average 
194 diameter of the zone of growth of 5.5 cm) and only mutants with > 75% motility as 
195 compared to the parent strain were selected for further study. 
196 
197 Location of transposon insertions. To determine the location of the transposon 
198 insertion point a plasmid rescue technique was carried out (Grant et al, 2005). 
199 Briefly the genomic D N A from each of the mutants was isolated and digested to 
200 completion with Bglll or Sspl. The genomic D N A fragments were then self-ligated 
201 and transformed by electroporation into E. coli Sll-'Xpir (Simon et al., 1983). 
202 Plasmids were prepared using the QIAprep spin miniprep kit (Qiagen, Crawley, UK) 
203 from a 10 ml overnight culture. The protocol was carried out according to the 
204 manufacturer's recommendations for large plasmids, which meant that the D N A was 
205 eluted from the spin-column using water heated to 70°C to maximise recovery. 
206 Recovered plasmid was then concentrated by ethanol precipitation and resuspended in 
207 5 ul of dH20. The insertion site was identified by D N A sequencing using a 
208 transposon specific primer (5'-CCCGGGAATCATTTGAAG- 3'). 
209 
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210 SNP Detection assay. A Single Nucleotide Polymorphism (SNP) detection assay to 
211 detect the observed polymorphisms in one of the mutated genes (CJ0490) was 
212 developed based on one previously reported (AbuOun et al., 2005). Primers were 
213 designed to the region flanking the TTT trinucleotide sequence (Figure 3A) (FWD: 
214 5'-AAAGAGCGATTGAAGC-3'; REV: 5' -CATTAAAACTTCGGTTAAGA-3') and the probe 
215 was generated from the 01/51 sequence i.e. containing the TTT trinucleotide sequence 
216 (underlined), but on the complimentary strand (5'-Cy5-
217 GCATTTTTGCGTATTAAACTAGCT-biotin-3'). The amplification was performed as 
218 follows: an initial denaturation step for 10 minutes at 95°C; which was followed by 41 
219 cycles, with 10 s at 94°C, 15 s at 55°C and 10 s at 74°C. Melting curve analysis was 
220 performed immediately after amplification by heating the product to 94°C (20°C/s), 
221 cooling to 45°C for 15 s, and then heating to 85°C (0.1°C/s). D N A from 01/51 and 
222 NCTC11168, and a no template D N A control were included in each run as controls. 
223 NCTC11168 was found to have a melting temperature of 61°C indicating the presence 
224 of the TT dinucleotide sequence and 01/51 had a higher melting temperature of 64 °C 
225 which indicated that the probe and sequence were identical, i.e. that 01/51 possesses 
226 the TTT trinucleotide sequence. 
227 
228 Mutagenesis ofCj0497. For mutagenesis of CJ0497 the gene was amplified from C. 
229 jejuni 01/51 and cloned into pBluescript (Stratagene) via pCR2.1TOPO™ 
230 (Invitrogen), a T-tailed cloning vector. The following primers were used for the 
231 amplification of CJ0497: CJ0497F: 5'- TTGATTTAAGGGTTATGAAGGC-3' and 
232 CJ0497R: 5'- AGCCTTAATCACATCTTTTGG-3'). There was a unique Bglll site in 
233 CJ0497 into which the C. coli kanamycin cassette, from pJMK30 (van Vliet et al., 
234 1998) (kindly provided by Professor Julian Ketley, University of Leicester, UK), was 
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235 cloned. Constructs with the kanamycin cassette in the same orientation as the 
236 disrupted gene (as determined by PCR analysis) to minimise the risk of polar effects 
237 since the kanamycin cassette does not bear transcription termination sequences were 
238 introduced into C. jejuni 01/51 by electrotransformation. Mutants were confirmed by 
239 PCR and Southern blot analysis. The approach of inserting the kanamycin cassette, 
240 lacking transcription termination sequences, in the same orientation as the gene to be 
241 inactivated has been reported previously (Elvers et al, 2004; Ge et al, 2005; Linton 
242 et al, 2002) and has been shown to be non-polar on downstream genes (Hickey et al., 
243 2000). 
244 
245 Phenotypic assays to characterise CJ0497 mutant. In order to further characterise the 
246 mutant in CJ0497 a number of phenotypic assays were carried out including 
247 microaerobic growth, aeration survival and autoagglutination. For all of these 
248 additional assays the bacteria were grown at 37°C for 48 hours on blood agar or 
249 mCCDA with 50 ug of kanamycin added per ml for the mutant. Bacterial growth was 
250 harvested from these plates and resuspended in 2.5 ml sterile PBS prior to use in the 
251 assays. Al l assays were carried out in triplicate. 
252 
253 For the growth curve an appropriate volume of this suspension was added to Mueller-
254 Hinton (MH) broth in a 96-well plate to make a final volume of 100 ul in a well and 
255 an absorbance of ~ 0.1 (OD 570nm). The plate was then incubated microaerobically 
256 with gentle shaking at 37°C. Regular absorbance readings were taken up to 30 hours. 
257 
258 For the aeration stress assay 2 ml of the resuspended culture was used to inoculate 200 
259 ml of pre-warmed Mueller Hinton broth (MHB). The culture was incubated 
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260 microaerobically with gentle shaking at 37°C for 24 hours. Following overnight 
O Q 1 
261 growth (approximately 10-10 CFUml" ), the culture was exposed to atmospheric 
262 oxygen at 37°C incubation continued for a further 6 hours. Samples were removed at 
263 hourly time points and viable counts performed. 
264 
265 The autoagglutination assay was performed following the protocol described 
266 elsewhere (Golden & Acheson, 2002). The absorbance of harvested cultures was 
267 adjusted to -1.0 at 600 nm in PBS and the actual absorbance was measured again. The 
268 bacterial suspension (2.0 ml) was transferred into sterile bijoux tubes and incubated 
269 undisturbed at 37°C microaerobically for 24 hours to allow the bacterial cells to 
270 autoagglutinate and settle to the bottom of the tube. One millilitre of the upper 
271 aqueous phase was then aspirated and the absorbance was measured at 600 nm. The 
272 level of autoagglutination was calculated by subtracting the absorbance of the aspirate 
273 collected after 24 hours from the initial absorbance measured at the start of 
274 incubation. 
275 
276 Statistical analysis. For this a paired Student's T test was performed using MS-Excel 
277 software. A probability value P < 0.01 indicated statistical significance. 
278 
279 
280 Results 
281 Generation of a random transposon mutant library in a hyper-invasive strain. Six 
282 clinical strains (01/38, 01/41, 01/51, 01/35, 01/10 and 01/04) were tested for their 
283 ability to undergo random transposition using the mariner-based in vitro transposon 
284 system, which had been optimised for transposition of C. jejuni NCTC11168, 81-176 
285 and M l . The generation of a random transposon mutant library was only found to be 
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286 successful in one of the clinical hyper-invasive strains, 01/51. This was a faecal 
287 isolate from a patient with C. jejuni gastroenteritis. No other information regarding 
288 the disease severity or symptoms is available. In order to hit every gene in the genome 
289 of 01/51 it would be necessary to screen around 4-5000 mutants however it was 
290 decided to screen an initial batch of up to 1000 mutants in the first instance. The 
291 initial batch of mutants was picked and stored for future use. 
292 
293 The randomness of the transposon insertions was determined by randomly selecting 
294 ten mutants and carrying out Southern blot hybridisations, using a fragment of the 
295 transposon as a probe (data not shown), as well as sequence analysis to determine the 
296 location of the transposon insertion point. From this initial screen there did not appear 
297 to be any bias towards a particular region of the genome or particular strand of the 
298 chromosome for the insertion point (data not shown). This level of randomness was in 
299 keeping with other strains such as the genome sequenced strain, NCTC11168 and 
300 strain M l . In addition the risk of siblings within the library was minimised by 
301 keeping the recovery time of the mutants, following transformation, to a minimum. It 
302 was anticipated, following analysis of 01/51 and the other strains to which this 
303 technique has been applied, that the maximum risk of siblings within the library is 2 
304 %. 
305 
306 Screening of the 01/51 transposon mutant library for defects in invasion and motility. 
307 The mutant library (n=864) was screened in an invasion assay using INT407 cells and 
308 174 mutants that showed minimal invasion in the preliminary screening assays were 
309 selected to assess motility. The mutants showed a wide range of motility phenotypes 
310 with nine mutants being non-motile and the remainder retaining motility ranging from 
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311 20% - 174% of the parent strain 01/51. As motility is important for invasion, an 
312 arbitrary cut-off for mutant selection was chosen and 40 mutants with > 75% motility 
313 as compared to wild-type strain, 01/51, were selected. The reduced invasion capacity 
314 of these selected mutants was confirmed using INT407 cells in a confirmatory 
315 standard invasion assay in which each mutant was tested in triplicate. A selection of 
316 mutants that showed a > 60% reduction in invasion in INT-407 cells were also 
317 checked for their ability to invade Caco-2 cells. Al l the tested mutants showed a 
318 similar reduction in invasion of Caco-2 cells compared to INT-407 cells (Table 1). 
319 The localisation of the transposon insertions was investigated in 26 mutants. 
320 
321 Location of the transposon insertions. The transposon insertion point was identified 
322 in 23 out of the 26 mutants by the plasmid rescue technique and sequencing using a 
323 transposon derived primer (Table 1). The transposon insertion site could not be 
324 determined in the remaining three mutants even after several attempts with alternative 
325 restriction enzymes. Southern blot analysis was also performed on a random selection 
326 of mutants to ensure that a single transposon had inserted into each mutant. Analysis 
327 showed one band in every mutant lane confirming that the transposon had inserted at 
328 one site in the genome of each mutant (data not shown). 
329 
330 Al l but three of the transposon insertions identified were found to be in genes which 
331 were also present in NCTC11168 (Table 1). Of the remaining three insertions one was 
332 in the gene, dtpT (di-/tripeptide transporter), which is present in other C. jejuni strains 
333 for which the genome sequences are now available, including C. jejuni strain RM1221 
334 (CJE0757) and C. jejuni strain 81116 (C8J-0613). The second was annotated as a 
335 capsule polysaccharide biosynthesis protein in C. jejuni subspecies doylei strain 
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336 269.97. In the third mutant (10D12) the sequence obtained showed homology to a 
337 putative rloE gene (CJJ26094_0063) in C. jejuni strain 260.94 whose sequence was 
338 incomplete at the time of searching (July 2009). The function of this gene is unknown 
339 and in other C. jejuni strains, namely 84-25 and Tghl33, it is annotated as a putative 
340 hypothetical protein. 
341 
342 In 8 out of the 23 mutants for which the transposon insertion point was determined, 
343 the transposon was located within a ca. 14 kb region of the genome between CJ0483 
344 and CJ0499, according to the genome sequence of NCTC11168 (Figure 1). The gene 
345 order in 01/51 was found to be similar to that in NCTC11168 as determined by PCR 
346 analysis across this region (Figure 1). Two of the genes located within this 14 kb 
347 region of the genome, CJ0490 and CJ0497 were identified as the site of transposon 
348 insertion in 3 and 2 separate mutants respectively. The position of the transposon in 
349 these two genes seems to have little effect on invasion, but a greater effect on motility 
350 (Table 1). For example the three mutants in CJ0490 were between 16-18% as invasive 
351 and between 78-174% as motile as the parent strain. 
352 
353 Genomic comparison of the 14kb region amongst other strains of C. jejuni revealed 
354 some conservation in gene order. Comparison of the 14 kb region (CJ0483 - CJ0499) 
355 of NCTC11168 with strain RM1221, another available C. jejuni genome sequence 
356 (TIGR), indicated that this region is similar in the two strains. However in RM1221 
357 between CJ0493 and CJ0494 there is an insertion of a c.40kb region of D N A (Figure 
358 1), which appears to have very few similarities to known sequences. This 40kb region 
359 has a GC content of 27.42% compared with an average of 30.31% for the RM1221 
360 genome (Fouts et al, 2005). Interestingly on further analysis of the NCTC11168 
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361 genome there is an additional small ORF located between CJ0494 and_/ksA (CJ0493) 
362 annotated as tRNA-Arg, however it is not known whether this tRNA gene also exists 
363 in 01/51 at this position. 
364 
365 Q0490 is annotated as two ORFs in NCTC11168, but is a single ORF in 01/51. 
366 CJ0490 was one of the genes for which there were 3 individual transposon mutants. 
367 In NCTC11168 CJ0490 encodes the aldehyde dehydrogenase C terminus whereas 
368 CJ0489 encodes the N - terminus of this same protein. Comparison of this sequence 
369 with that in other bacteria, such as E. coli, Shigella flexneri and Neisseria 
370 meningitidis, indicated that it is unusual to find the two parts of this protein encoded 
371 by separate genes. The sequence of this aldehyde dehydrogenase was therefore 
372 determined in the hyper-invasive strain, 01/51, and interestingly this gene was also 
373 found to be a single ORF with both the N-terminus and C-terminus together, as in 
374 other bacteria. At the D N A level in NCTC11168 a single T deletion appears to have 
375 resulted in the generation of a stop codon (Figure 2A), which is followed by an 
376 intergenic region of 36 nucleotides before the start of the next ORF. At the amino acid 
377 level (Figure 2B) the stop codon causes a frameshift and the appearance of the 
378 separate N and C termini. 
379 
380 The presence of the TTT trinucleotide sequence was investigated in seven C. jejuni 
381 strains by sequencing across the region between CJ0489 and CJ0490 and in a further 
382 20 strains with known invasion potential using a SNP detection assay. There was no 
383 correlation between the presence of the TTT trinucleotide and the invasion potential 
384 therefore further analysis of this gene was not carried out. 
385 
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386 Targeted mutagenesis ofCj0497 in 01/51 reveals a potential adhesin. As the mutants 
387 with transposon insertions in CJ0497 (1B5 and 1D1) both showed reduced invasion, 
388 yet retained motility, compared to the wild-type 01/51, this gene was selected for 
389 further study. This gene was independently inactivated in C. jejuni strain 01/51 by 
390 insertion of a kanamycin resistance cassette to confirm the observations with the 
391 transposon mutant. The resulting targeted mutant was tested in assays of association 
392 and invasion and was significantly reduced in overall association with INT-407 (4% 
393 of inoculum associated for mutant vs. 9.5% for 01/51; p< 0.01) and Caco-2 cells 
394 (0.7% of inoculum associated for mutant vs. 3% for 01/51, p< 0.01) and invasion into 
395 INT-407 (0.11% of inoculum internalised vs. 1% for 01/51; p< 0.01) and Caco-2 cells 
396 (0.004% of inoculum internalised for mutant vs. 0.39% for 01/51; p< 0.01) compared 
397 to the wild-type strain 01/51 which suggests that the reduction in invasion in the 
398 CJ0497 mutant may be due to a reduction in adhesion. The mutant was also found to 
399 grow as well under microaerobic conditions as the wild-type strain and to survive as 
400 well under atmospheric oxygen conditions. In addition the targeted mutant was found 
401 to be 1.3 times more motile (p<0.001) and 1.3 times better able to autoagglutinate 
402 (p<0.001) than the wild-type strain. 
403 
404 Discussion. 
405 C. jejuni is the most common cause of bacterial food-borne diarrhoea worldwide, but 
406 its pathogenic mechanisms are not clear. However, previous studies indicate that 
407 invasion and motility are important for Campylobacter pathogenesis and not all 
408 strains have the same virulence potential. C. jejuni strain dependent variability in 
409 invasion into eukaryotic cells has been reported by many researchers (Everest et al., 
410 1992; Konkel & Joens, 1989; Malik-Kale et al., 2007; Newell et al, 1985). The 
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411 invasiveness of C jejuni strains is generally low making investigation of this property 
412 difficult, however, we recently reported the identification of hyper-invasive strains of 
413 C jejuni (Fearnley et al, 2008). A transposon mutant library was constructed in one 
414 of these hyper-invasive strains (01/51) in order to investigate the molecular basis of 
415 invasion and 26 mutants with reduced invasion were selected for further study and 
416 identification of the genes inactivated. 
417 
418 Only one of the genes identified was found to be previously associated with invasion. 
419 Mutant 3A10 has a transposon insertion in cipA (CJ0685) a putative Campylobacter 
420 invasion protein). A previous study reported that a mutation in the cipA gene of 
421 C. jejuni TGH9011 resulted in the reduced invasion of HEp-2 cells but there was no 
422 change in invasion of INT-407 and Caco-2 cells (Lynett, 1999). This gene was 
423 identified in our study as being involved in invasion in both INT-407 and Caco-2 
424 cells. In previous annotations of the Campylobacter genome this gene was annotated 
425 as a sugar transferase with similarity to two genes involved in capsule biosynthesis 
426 (Cj 1421c and Cj 1422c). It is possible therefore that a mutation in this gene has altered 
427 some surface property of the organism resulting in reduced invasion and this gene is 
428 currently being investigated further. 
429 
430 The fact that 8 of the 23 mutants in this study had transposon insertions within one 
431 region of the genome is interesting. There was no apparent bias in the insertion point 
432 when an initial ten mutants were screened to check whether the transposition was 
433 random and none of those ten mutants possessed a transposon insertion in this 14 kb 
434 region. It is possible that this 14 kb region has a role in the interaction of C jejuni 
435 with its host; however this region does appear to be associated with genomic 
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436 variability. The sequence between CJ0483 and CJ0499, overlaps with one of the seven 
437 hypervariable plasticity regions, PR, previously described in the genome of C. jejuni 
438 which are likely to reflect the high level of phenotypic variation seen amongst the C. 
439 jejuni population and account for the ability of this organism to exist in a wide range 
440 of ecological niches (Pearson et al, 2003). Moreover further analysis of this region 
441 revealed that in C. jejuni RM1221 there appears to be a large D N A insertion at this 
442 point (CJIE2) which has integrated into the 3'- end of an arginyl tRNA gene (Fouts et 
443 al., 2005) and may represent an intact prophage or a genomic island which highlights 
444 the genetic diversity within this region. 
445 
446 Many of the genes into which the transposons have inserted are genes associated with 
447 metabolism and survival e.g. putA (Cj 1503c), a putative proline dehydrogenase/delta-
448 l-pyrroline-5-carboxylate dehydrogenase, which catalyses the oxidation of proline 
449 into glutamate; aid (CJ0490), aldehyde dehydrogenase, involved in energy acquisition 
450 and amino acid transport; uxaA (CJ0483), altronate hydrolase, involved in 
451 carbohydrate metabolism; CJ0519, involved in molybdopterin biosynthesis; surE, a 
452 putative stationary-phase survival protein; dtpT encoding a di-tripeptide transporter 
453 protein. 
454 
455 Interestingly the aldehyde dehydrogenase gene (CJ0490) is polymorphic in those 
456 strains in which it is present and it is only present in five of the eight C. jejuni genome 
457 sequences currently available suggesting that this gene is non-essential for 
458 metabolism and may even be a pseudogene (http://xbase.bham.ac.uk/campydb/). 
459 
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460 The lack of well-defined virulence mechanisms in C. jejuni and the involvement of 
461 metabolism associated genes with virulence phenotypes may reflect the possibility 
462 that C. jejuni is an opportunistic pathogen and does not possess specific virulence 
463 factors as in other bacteria, with disease resulting as a consequence of the need of the 
464 organism to grow and survive within the human host. The fact that many of these 
465 genes are part of different metabolic pathways highlights that invasion is a multi-
466 faceted phenotype, involving many different pathways. 
467 
468 The transposon in two mutants (1B5 and 1D1) was located within CJ0497, which is 
469 annotated as a putative lipoprotein. Further analysis of this gene sequence indicates 
470 that it contains a signal peptide, suggesting that it might be located in the periplasm 
471 and is likely to be membrane-bound. It also contains a tetratricopeptide repeat (TPR) 
472 region found in multi-protein complexes and transmembrane segments. TPR motifs 
473 are thought to mediate inter- and intra-molecular protein interactions and occur widely 
474 in nature (Ohara et al, 1999). In bacteria TPR repeat containing proteins are thought 
475 to have a role in gene regulation, flagellar motor function and virulence (Newton et 
476 al, 2007). Moreover in Legionella pneumophila, two TPR containing genes IpnE and 
477 enhC have been shown to be associated with entry into human tissue culture cell lines 
478 (Cirillo et al, 2000; Newton et al, 2006). 
479 
480 Targeted insertional inactivation of CJ0497 resulted in a reduction in bacterial 
481 association and invasion which suggests that this gene may have a role in host cell 
482 adhesion, which may lead to invasion. Further phenotypic studies indicated that the 
483 mutant was unaffected in its ability to grow under microaerobic conditions or to 
484 survive in air compared to the wild-type and so the reduction in invasion could not be 
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485 attributed to either of these factors. The mutant was however more motile and better 
486 able to autoagglutinate than the wild-type, suggesting that a loss of this gene does not 
487 result in reduced motility or autoagglutination. A similar finding was reported 
488 previously whereby a mutation in a known adhesin gene, peblA, failed to reduce the 
489 level of autoagglutination compared to the wild-type strain (Misawa & Blaser, 2000). 
490 This could mean that the mechanisms used by the organism to adhere to cells are 
491 different to those used to adhere to each other and in the case of CJ0497, if it were to 
492 encode an adhesin, by removing it, autoagglutination was increased. The reason for 
493 this is unclear but may indicate enhanced exposure of other surface molecules that are 
494 involved in the autoagglutination process. 
495 
496 A number of adhesins have been identified in C. jejuni including P E B l (Kervella et 
497 al, 1993; Pei & Blaser, 1993), CadF (Konkel et al, 1997) and JlpA (Jin et al, 2001). 
498 The role of CJ0497 as a lipoprotein and adhesin in C. jejuni warrants further 
499 investigation as it does appear to be present in all C. jejuni strains tested to date and is 
500 not species-specific like jlpA, as it is present in the genome sequence of C. coli, C. 
501 upsaliensis and C. lari as well as other members of the epsilon subdivision of the 
502 proteobacteria (http://xbase.bham.ac.uk/campydb/). 
503 
504 We have identified a number of previously uncharacterised genes with a potential role 
505 in host cell invasion. The advantage of this study was that a hyper-invasive strain of 
506 C. jejuni was used for transposon mutagenesis which facilitated the detection of 
507 mutants with reduced invasion. Many of the genes are annotated as metabolism-
508 associated rather than "virulence" per se and many appear to be conserved within the 
509 species. In addition this study has also highlighted a region of the genome that may be 
20 
510 involved in genomic variability between strains. Further investigation of some of the 
511 genes described through targeted mutation as well as complementation studies is 
512 currently underway which will help to provide greater insight into the molecular basis 
513 of the observed variation in virulence in C. jejuni. 
514 
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731 Figure Legends 
732 
733 Figure 1: Location of the transposon insertions in the 14 kb region between 
734 CJ0483 and CJ0499. ORFs with transposon insertions are shown as black arrows. 
735 The shaded inverted triangle represents the position in C. jejuni strain RM1221 where 
736 there is an insertion of c. 40 kb. The direction of the arrow denotes the predicted 
737 direction of transcription. The dotted arrow at the bottom represents the region 
738 confirmed by P C R analysis in C. jejuni 01/51 as having the same gene order as 
739 NCTC11168. This region, flanked by altronate hydrolase C-terminus (CJ0483) and a 
740 putative histidine triad (HIT) family protein (CJ499), contains genes encoding a 
741 putative M F S (Major Facilitator Superfamily) transport protein (CJ0484), a putative 
742 oxidoreductase (CJ0485), a putative sugar transporter (CJ0486), a putative 
743 amidohydrolase (CJ0487), two conserved hypothetical proteins (CJ0488 and CJ0496), 
744 a putative aldehyde dehydrogenase N and C terminus (CJ0489 and CJ0490), 30S 
745 ribosomal proteins S12 and S7 (CJ0491 and CJ0492), fusA elongation factor G 
746 (CJ0493), a putative exporting protein (CJ0494), a putative methyltransferase domain 
747 protein (CJ0495), a putative lipoprotein (CJ0497) and trpC, an indole-3-glycerol 
748 phosphate synthase (CJ0498). 
749 
750 Figure 2: (A) DNA sequence of the CJ0489 - CJ0490 region in NCTC11168 
751 compared with that in 01/51. The dark grey boxes highlight single nucleotide 
752 polymorphisms in the sequence between the two strains and the T T T trinucleotide 
753 present in 01/51 compared with the T T dinucleotide in NCTC11168. The arrow 
754 highlights the deletion of a single T nucleotide in NCTC11168 which results in a stop 
755 codon ( T A A ) . The light grey and clear boxes highlight the primers and probe used in 
756 the melting curve assay respectively. (B) The predicted amino acid sequence of the 
757 CJ0489-CJ0490 region in NCTC11168 compared with 01/51. The whole reading 
758 frame is open for 01/51 from the beginning to end. The underlined sequence is the 
759 NCTC11168 sequence for CJ0489, terminating in a stop codon (.), which then brings 
760 about a frame shift before the start (arrow) of the CJ0490 sequence. The shaded box 
761 highlights an intervening sequence in NCTC11168 which is not translated into the 
762 final protein sequence. 
763 
764 
765 
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766 Table 1: Location of the transposon insertion point in 26 selected mutants with 
767 reduced invasion compared with the parent strain 01/51. Invasion potential and 
768 motility are also given. Mutants are arranged according to functional classification 
769 (http://xbase.bham.ac.uk/campydb/). 
Mutant INT-407 Caco-2 Motility 
Invasion51 Invasion51 
Location and annotation 
Adaptations and atypical conditions 
10D2 40 n/d 
Central intermediary metabolism 
1C1 
1C5 
1F4 
1F3 
19 
16 
26 
1 
n/d 
n/d 
n/d 
Conserved hypothetical proteins 
10D10 3 2 
Degradation- amino acids 
10H3 6 4 
105 
104 
174 
78 
165 
76 
88 
CJ0293 surE, stationary phase 
survival 
CJ0490 aid, aldehyde 
dehydrogenase C-
terminus(571/1182)c 
CJ0490 aid, aldehyde 
dehydrogenase C-
terminus (139/1182) 
CJ0490 aid, aldehyde 
dehydrogenase C-
terminus (929/1182) 
Cj 04 8 3 uxaX altronate 
hydrolase C-terminus 
Cj 1555c hypothetical protein 
Cj 1503 c putative proline 
dehydrogenase 
DNA replication, restriction modification, recombination and repair 
6A9 37 40 82 Cj 0690c putative restriction/ 
modification enzyme 
Energy metabolism- Electron transport 
3H7 
Membrane 
1B5 
1D1 
10H1 
2 
s, lipoproteins 
14 
15 
2 
Signal transduction 
3E9 4 
<1 
and porins 
n/dc 
n/d 
3 
n/d 
82 
83 
100 
88 
100 
Cj 1020c 
Q0497 
Q0497 
Cj 1245c 
flgs 
putative cytochrome 
C 
putative lipoprotein 
(308/1278) 
putative lipoprotein 
(563/1278) 
putative membrane 
protein 
signal transduction 
histidine kinase 
Surface polysaccharides, lipopolysaccharides and antigens 
3A10 1 2 88 Cj0685c invasion protein cipA 
9D2 2 26 92 JJD26997 capsule 
1801 polysaccharide 
biosynthesis protein 
of C. jejuni subsp. 
doylei 269.97 
10E9 3 6 88 CJ1136 putative 
28 
Transport- Anions 
6A7 11 
glycosyltransferase 
86 Cj 1539c putative anion-uptake 
ABC-transport 
system permease 
Transport- Carbohydrates, organic acids and alcohols 
1D7 10 100 Q0486 
Transport- Peptides 
1H10 0 
Unknown function/miscellaneous 
putative sugar 
transporter 
92 
1H6 
3H8 
10D12 
10H12 
0 n/d 
1 
Location not yet determined 
10A4 8 
10E11 2 
10H2 <1 
4 
3 
<1 
75 
82 
76 
96 
98 
94 
112 
dtp! di-tripeptide 
transporter protein 
not present in 
NCTC11168 
Cj 0519 putative rhodanese-
like domain protein; 
molybdopterin 
biosynthesis protein 
Cj 0499 putative HIT family 
protein 
rloE putative hypothetical 
protein, C. jejuni 
260.94 
Cj 1305c hypothetical protein 
not determined 
not determined 
not determined 
770 a: Invasiveness is presented as a percentage of the invasiveness of the parent strain 
771 01/51. The figure given is the mean of three replicates from within a single assay. 
772 Each assay was repeated at least once more. 
773 b: Motility is presented as a percentage of the motility of the wild-type. The figure 
774 given is the mean of three replicates 
775 c: Nucleotide position of the transposons in CJ0490 and Cj0497/the length of both 
776 genes(bp) 
29 
Figure 1 
10 O 
~i r 
CO 
Q 
-H-\-
o 
.£> .C> .£> 
C> C> C> 
0 > — 
RM1221 
10 
CD 
CO 
X 
CO 
/ 
C? 
X && 
6^  
5000 
J 1_ J [_ 
10000 
J L J L 
CJ0483-CJ0499 (14240 bp) 
Figure 2A 
11168 
01/51 
11168 
01/51 
11168 
01/51 
11168 
01/51 
11168 
01/51 
Figure 2B 
a t g a c a a c t t a t t t a a a t t a t a t 
a t g a c a a c t t a t t t a a a t t a t a t 
tgatggaaagtttatcccacataatggagaatttatcgaagttttaaatccagctaccaaagaagtgatt 
tgatggaaagtttatcccacataatggagaatttatcgaagttttaaatccagctaccaaagaagtgatt 
Forward 
tcaagagtagctagcgcttctttagaagatactaaaagagcgattgaagcagc|cjaaaaaagcacaaaaag 
tcaagagtagctagcgct tc t t tagaagatactaaaagagcgat tgaagca gqtjaaaaaagcacaaaaag i 
t t tgggaggc taaaccagcgattgaaagagcaaatcatt taaaagaaat agctac t t 
t t tgggaggujtaaaccagcgattgaaagagcaaatcatttaaaagaaatagct a qtttj aatacgcaaaaa 
aatacgcaaaaa 
tgc: taat t tc t taaccgaagt t t taa tgcaagagcaaggaaaaaccagagt t t tggctagcatagagat t 
_tf l£rtaat t tct taaccgaagtt t taatgcaagagcaaggaaaaaccagagtt t tggctagcatagagatt 
Reverse 
01/51 MTTYLNYIDGKFIPHNGEFIEVLNPATKEVISRVASASLEDTKRAIEAAKKAQ 
11168 MTTYLNYIDGKFIPHNGEFIEVLNPATKEVISRVASASLEDTKRAIEAAKKAQ 
01/51 KVWEVKPAIERAN H LKEIASLIRKN AN FLTE VLMQEQG KTRVLASIEIN FTAD 
11168 KVWEVKPAI ERAN H LKE I AS-
11168 LIRKNANFLTEVL 
11168 MQEQGKTRVLASIEINFTAD 
01/51 YMDYTAEWARRYEGEIIQSDRANEHIYLYKSAIGVIGGILPWNFPFFLIARKM 
11168 YMDYTAEWARRYEGEIIQSDRANEHIYLYKSAIGVIGGILPWNFPFFLIARKM 
